
Cancer vaccines that use tumor zzso zzso as a source of zzso zzso zzso have significant potential for generating therapeutic zzso immune zzso zzso encompassing zzso bypass the limitations of single zzso vaccines by simultaneously stimulating immunity against multiple zzso thereby broadening the repertoire of zzso zzso clones available for zzso Administration of zzso in particulate form, such as when zzso in zzso zzso increases its zzso capacity and produces more robust immune responses than when zzso is given in soluble zzso These effects can be further enhanced by zzso zzso with zzso A number of recent studies using zzso zzso delivery of zzso with or without zzso have produced promising results in zzso zzso In this review, we will discuss current experimental approaches involving zzso being pursued in the zzso field, and comment on strategies such as combining specific zzso agents with zzso zzso delivery that may eventually lead to improved survival outcomes for cancer zzso 

